Hispanic Broadcasting Newswire

Comprehensive Real-Time News Feed for Hispanic Broadcasting.

Results 1 - 20 of 192 in Hispanic Broadcasting

  1. Hertz has positive read through from United Rentals results, says Wells FargoRead the original story

    Wednesday Apr 9 | Theflyonthewall.com

    Hertz has positive read through from United Rentals results, says Wells Fargo After United Rentals reported stronger than expected Q1 results, Wells Fargo thinks the company's results have positive implications for Hertz's equipment rental unit.

    Comment?

  2. Hospira Coverage Initiated at Sterne AgeeRead the original story

    Yesterday | AmericanBankingNews.com

    The firm set a "neutral" rating and a $39.00 price target on the stock. Sterne Agee's price target points to a potential downside of 10.09% from the company's current price.

    Comment?

  3. Best And Worst Health Care Sector ETFs, Mutual Funds And Key HoldingsRead the original story w/Photo

    Yesterday | Seeking Alpha

    The Health Care sector ranks seventh out of the ten sectors as detailed in my Sector Rankings for ETFs and Mutual Funds report.

    Comment?

  4. Hertz initiated with a Buy at GabelliRead the original story w/Photo

    Wednesday Apr 9 | Theflyonthewall.com

    On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: A10 Networks initiated with a Buy at BofA/Merrill... Actavis initiated with a Buy at Sterne Agee... Allergan initiated with a Buy at Sterne Agee... Autohome initiated with a Neutral at Credit Suisse... BitAuto initiated with an Outperform at Credit Suisse... Centene ... (more)

    Comment?

  5. Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement...Read the original story

    Friday Apr 11 | Sys-Con Media

    Today, Analysts Review released its analysts' notes regarding Actavis plc , The Medicines Company , Hospira, Inc. , Horizon Pharma, Inc. , and Galectin Therapeutics Inc. .

    Comment?

  6. Hospira Wins U.K. Court Challenge to Roche Cancer-Drug PatentsRead the original story

    Thursday Apr 10 | The Washington Post

    Hospira Inc.'s U.K. unit won a court ruling overturning two patents for Roche Holding AG's top- selling breast-cancer drug Herceptin, paving the way for the generic drug-maker to sell a cheaper competitor in the country.

    Comment?

  7. District Court in San Diego Finds in Favor of Ivera; Denies Hospira's MotionRead the original story

    Thursday Apr 10 | Sys-Con Media

    Ivera has also asserted these patents against Excelsior Medical Corporation and Catheter Connections, Inc., and the cases are set to go to trial in San Diego starting this July.

    Comment?

  8. Critical Shortage Of Injectables Create Opportunity For DrugmakersRead the original story

    Wednesday Apr 9 | Seeking Alpha

    Low profit margin, strict regulation, and costly investments are turning companies away from the industry, leaving profitable opportunities for firms that remain.

    Comment?

  9. BioTime to Present at 13th Annual Needham Healthcare ConferenceRead the original story

    Monday Apr 7 | Freshnews

    BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 13th Annual Needham Healthcare Conference to be held April 8-9, 2014 in New York City.

    Comment?

  10. Hospira sent FDA warning letter over inspection of device facilityRead the original story

    Wednesday Mar 26 | Theflyonthewall.com

    The Medicines Co. downgraded to Neutral from Overweight at Piper Jaffray Piper Jaffray downgraded The Medicines Co.

    Comment?

  11. The Medicines Co. downgraded to Neutral from Overweight at Piper JaffrayRead the original story

    Wednesday Mar 26 | Theflyonthewall.com

    The Medicines Co. downgraded to Neutral from Overweight at Piper Jaffray Piper Jaffray downgraded The Medicines Co.

    Comment?

  12. Us Stocks-Wall St climbs to record after manufacturing dataRead the original story

    Tuesday Apr 1 | Reuters

    U.S. stocks opened the second quarter on a higher note on Tuesday, with the S&P 500 hitting a record high, after data on manufacturing indicated economic growth was gaining traction after a harsh winter.

    Comment?

  13. Wall Street climbs to record after manufacturing dataRead the original story

    Tuesday Apr 1 | Buenos Aires Herald

    US stocks opened the second quarter on a higher note, with the S&P 500 hitting a record high, after data on manufacturing indicated economic growth was gaining traction after a harsh winter.

    Comment?

  14. The Medicines Company Release: Update On Angiomax (Bivalirudin) Patent LitigationRead the original story

    Tuesday Apr 1 | BioSpace

    On March 31, 2014, Judge Andrews in the U.S. District Court of Delaware issued his Trial Opinion in The Medicines Company v.

    Comment?

  15. Hospira, Inc. To Host Conference Call For First-Quarter 2014 ResultsRead the original story

    Tuesday Apr 1 | BioSpace

    A live webcast of the conference call and related material will be available on Hospira's website at www.hospirainvestor.com .

    Comment?

  16. The Medicines Co. gaps down, levels to watchRead the original story

    Sunday Mar 30 | Theflyonthewall.com

    The Medicines Co. price target lowered to $32 from $39 at JPMorgan JPMorgan lowered its price target for The Medicines Company to $32 after the U.S. Court in Delaware ruled the company failed to prove that Hospira's generic Angiomax product infringed its patents.

    Comment?

  17. Update on Angiomax(R) (Bivalirudin) Patent LitigationRead the original story

    Monday Mar 31 | Freshnews

    On March 31, 2014, Judge Andrews in the U.S. District Court of Delaware issued his Trial Opinion in The Medicines Company v.

    Comment?

  18. The Medicines Co. provides update on Angiomax patent litigationRead the original story

    Wednesday Mar 26 | Theflyonthewall.com

    The Medicines Co. price target lowered to $32 from $39 at JPMorgan JPMorgan lowered its price target for The Medicines Company to $32 after the U.S. Court in Delaware ruled the company failed to prove that Hospira's generic Angiomax product infringed its patents.

    Comment?

  19. Hospira agrees to $60 mln settlement over quality control problemsRead the original story

    Thursday Mar 27 | Reuters

    Hospira Inc has agreed to pay $60 million to resolve a class action lawsuit accusing the drug maker of misleading investors about quality control problems that undermined an initiative to improve the company's margins and operations.

    Comment?

  20. Hospira's TheraDoca Infection Control Assistanta Ranked #1...Read the original story

    Thursday Mar 27 | Sys-Con Media

    The full report is available at www.KLASresearch.com . The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

    Comment?